Tag: ATMP
Using Ultra-Low Freezers to Maintain the Viability of Cell and Gene Therapy Products
Many cell and gene therapy solutions have shown considerable promise as a source of possible treatments for a wide range of chronic disorders. However, these sophisticated therapies introduce additional barriers such as the requirements for ultra-low and cryogenic storage,...
Sigilon Therapeutics’ Lead Cell Therapy Product Granted ATMP Designation By EMA
Sigilon Therapeutics is an early stage (preclinical) biotechnology company developing an encapsulated cell therapy technology. Its Afibromer™ Living Therapeutic candidate SIG-003 has been granted an Advanced Therapy Medicinal Product (ATMP) designation by the Committee for Advanced Therapies of the...